Quick Links

The Neuro

Breakthrough in MS treatment

Drug shown to reduce new attacks/symptom progression in some patients
Mon, 2017-01-09 10:44

In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS.

Three studies conducted by an international team of researchers, which included Amit Bar-Or and Douglas Arnold from the Montreal Neurological Institute and Hospital of McGill University, have discovered that ocrelizumab can significantly reduce new attacks in patients with relapsing MS, as well as slow the progression of symptoms caused by primary progressive MS.

Contact Information

Contact: Shawn Hayward
Organization: Montreal Neurological Institute & Hospital
Email:
Office Phone: 514 398-3376
Category:
Source Site: /newsroom

50th anniversary of "Pain Mechanisms: A New Theory"

Tue, 2015-11-17 13:39

November 19 marks the 50th anniversary of the ground-breaking paper, “Pain Mechanisms: A New Theory” co-authored by McGill’s Ronald Melzack, and the late Patrick Wall, which introduced gate-control theory.

Contact Information

Contact: Cynthia Lee
Organization: Media Relations Office
Email:
Office Phone: (514) 398-6754
Category:
Source Site: /newsroom

May - Multiple Sclerosis Awareness Month

Thu, 2015-05-07 09:41

The Montreal Neurological Institute and Hospital – The Neuro at McGill University and the MUHC has Canada’s oldest MS clinic but is always innovating - striving for progress and better treatments for patients.

What’s new in MS at The Neuro

Contact Information

Contact: Anita Kar
Organization: The Neuro
Email:
Category:
Source Site: /neuro

McGill-led projects awarded Brain Canada grants

Program supports innovative research to advance understanding of the brain and brain diseases
Fri, 2014-09-12 12:05

Four innovative projects led by McGill University researchers have been selected to receive major grants under the Canada Brain Research Fund.

Contact Information

Contact: Chris Chipello
Organization: Media Relations Office
Email:
Office Phone: 514 398-4201

Secondary Contact Information

Contact: Anita Kar
Organization: Montreal Neurological Institute
Office Phone: 514-398-3376
Category:
Source Site: /newsroom

Desjardins Group and The Neuro – training the next generation of neuroscientists

Wed, 2013-09-04 10:39

As part of The Neuro’s Thinking Ahead Campaign, a $240,000 donation from Desjardins Group, the largest financial cooperative group in Canada, to The Montreal Neurological Institute and Hospital – The Neuro, McGill University has enabled the creation of the Desjardins Outstanding Student Award. Twelve awards of 20 000 $ each will support top-rated graduate students and postdoctoral fellows who are advancing research to better understand the nervous system and neurological disorders and aid in developing new therapies.

Category:

POSTPONED: The Dorothy J. Killam Lecture

Mon, 2013-04-29 16:00 - 17:30
Montreal Neurological Institute : Jeanne Timmins Amphitheatre, 3801 rue University Montreal Quebec Canada , H3A 2B4
Price: no cost

The Dorothy J. Killam Lecture was established at The Neuro in 2004 to recognize women of influence in business, science, politics or the humanities, and is named after an extraordinary woman who, together with her husband, made immense contributions to Canadian education and science.

Contact Information

Contact: Debbie Rashcovsky
Organization: Montreal Neurological Institute and Hospital
Email:
Office Phone: 514-398-6047

Guy Rouleau appointed director of The Neuro

Joint Message from Prof. Heather Munroe-Blum, Principal and Vice-Chancellor, McGill University, Mr. Normand Rinfret, Director General and Chief Executive Officer, McGill University Health Centre and Dr. David Eidelman, Vice-Principal (Health Affairs) and Dean of Medicine, McGill University
Thu, 2012-11-08 14:33

 

Category:
Source Site: /newsroom